Artiva Biotherapeutics Inc (ARTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | |
| Sales | 26,656 | 3,497 |
| Gross Profit | 26,656 | 3,497 |
| Operating Expenses | 15,845 | 15,321 |
| Operating Income | 10,811 | -11,824 |
| Other Income | 468 | 540 |
| Pre-tax Income | 11,279 | -11,284 |
| Net Income Continuous | 11,279 | -11,284 |
| Net Income | $11,279 | $-11,284 |
| EPS Basic Total Ops | 13.98 | -14.09 |
| EPS Basic Continuous Ops | 13.98 | -14.09 |
| EPS Diluted Total Ops | 1.62 | -14.09 |
| EPS Diluted Continuous Ops | 1.62 | -14.09 |
| EBITDA(a) | $11,367 | $-11,824 |